Laurence Zitvogel

This inventor holds 24 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Institut Gustave Roussy, National Institute of Health and Medical Research, Université Paris-Saclay. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence Zitvogel. Retrieved from https://idiyas.com/inventor/laurence-zitvogel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 13)

% Patents Active = 70.8

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 15 (Patent Applications = 25)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 90(Granted Patents)

Location History:

Antony, FR (2008 - 2013)
Villejuif, FR (2021)
Paris, FR (2004 - 2023)

Company Filing History:

21 out of 101

Institut Gustave Roussy

patents

9 out of 1,853

National Institute of Health and Medical Research

patents

5 out of 101

Université Paris-Saclay

patents

4. 2 out of 49

Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement

Centre Hospitalier Universitaire De Rennes

patent

8. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

9. 1 out of 1

Insitut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement (Inrae)

patent

10. 1 out of 2

Institut De La Recherche Agronomique

13. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Oncolytic Virus

Immune Checkpoint Inhibitors

Microbiota Composition

Cancer Treatment

Immunogenic Sequences

Natural Killer Cells

Chemotherapy Responsiveness

Toll Like Receptor Agonists

Antigen-Presenting Cells

Cancer Prognosis

Gastrointestinal Sarcoma

Protein Phosphatase Inhibitors

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622937 - Combination of oncolytic virus with immune checkpoint modulators (2026-05-12),

2. 12551515 - METHODS AND COMPOSITIONS FOR TREATING CANCER (2026-02-17),

3. 12246044 - Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same (2025-03-11),

4. 12239686 - Immune checkpoint inhibitor combinations (2025-03-04),

5. 12144839 - Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 AB-based treatment (2024-11-19),

6. 12102672 - Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer (2024-10-01),

7. 11684640 - Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 ab-based (2023-06-27),

8. 11344586 - Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment (2022-05-31),

9. 11083774 - Immune checkpoint inhibitor combinations (2021-08-10),

10. 10765710 - Combination of oncolytic virus with immune checkpoint modulators (2020-09-08),

11. 10646521 - Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment (2020-05-12),

12. 9810692 - Methods for predicting the sensitivity of a subject to immunotherapy (2017-11-07),

13. 9593376 - Natural killer p30 (NKp30) dysfunction and the biological applications thereof (2017-03-14),

14. 9557333 - Methods of treating gastrointestinal sarcoma patients depending on their sB7H6 serum level (2017-01-31),

15. 8865653 - Method of treatment for immunogenic treatment resistant cancer (2014-10-21),

Title: The Innovative Mind of Laurence Zitvogel

Introduction: Laurence Zitvogel is a pioneering female inventor based in Paris, France, known for her groundbreaking contributions to the field of medical research and immunotherapy.

Latest Patents: Laurence Zitvogel holds several patents related to novel cancer treatment methods utilizing the body's immune system to target and destroy cancer cells effectively.

Career Highlights: With a distinguished career in oncology and immunotherapy, Laurence Zitvogel has been at the forefront of developing innovative approaches to cancer treatment, focusing on personalized medicine and immunological interventions.

Collaborations: Throughout her career, Laurence Zitvogel has collaborated with leading researchers, pharmaceutical companies, and medical institutions worldwide to further advance the field of immunotherapy and cancer research.

Conclusion: Laurence Zitvogel's dedication to pushing the boundaries of medical science and her relentless pursuit of innovative solutions have solidified her reputation as a trailblazing inventor in the field of oncology and immunotherapy.

Profile summary based on public USPTO records.